Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-165.6%
operating margin TTM
-158.45%
revenue TTM
642.39 Thousand
revenue per share TTM
0.01$
valuation ratios | |
|---|---|
| pe ratio | -6.64 |
| peg ratio | -0.75 |
| price to book ratio | 29.32 |
| price to sales ratio | 11.03 |
| enterprise value multiple | -7.66 |
| price fair value | 29.32 |
profitability ratios | |
|---|---|
| gross profit margin | 95.96% |
| operating profit margin | -158.45% |
| pretax profit margin | -165.6% |
| net profit margin | -165.6% |
| return on assets | -53.88% |
| return on equity | -206.62% |
| return on capital employed | -66.67% |
liquidity ratios | |
|---|---|
| current ratio | 4.40 |
| quick ratio | 4.12 |
| cash ratio | 1.12 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 1,715.24 |
| operating cycle | 1,795.70 |
| days of payables outstanding | 868.25 |
| cash conversion cycle | 927.45 |
| receivables turnover | 4.54 |
| payables turnover | 0.42 |
| inventory turnover | 0.21 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.65 |
| debt equity ratio | 5.36 |
| long term debt to capitalization | 0.84 |
| total debt to capitalization | 0.84 |
| interest coverage | -3.81 |
| cash flow to debt ratio | -0.93 |
cash flow ratios | |
|---|---|
| free cash flow per share | -3.73 |
| cash per share | 4.55 |
| operating cash flow per share | -3.73 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | -0.93 |
| short term coverage ratios | -684.28 |
| capital expenditure coverage ratio | -1,727.17 |
Frequently Asked Questions
When was the last time Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) reported earnings?
Syndax Pharmaceuticals, Inc. (SNDX) published its most recent earnings results on 03-11-2025.
What is Syndax Pharmaceuticals, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX)'s trailing twelve months ROE is -206.62%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Syndax Pharmaceuticals, Inc. (SNDX) currently has a ROA of -53.88%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did SNDX's net profit margin stand at?
SNDX reported a profit margin of -165.6% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is SNDX's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 4.40 in the most recent quarter. The quick ratio stood at 4.12, with a Debt/Eq ratio of 5.36.